Vitamin-D-Free Regimen Intensifies the Spatial Learning Deficit in Alzheimer's Disease

REFERENCES

• Abeliovich, A., Paylor, R., Chen, C., Kim, J. J., Wehner, J. M., & Tonegawa, S. (1993). PKC mutant mice exhibit mild deficits in spatial and contextual learning. Cell, 75, 1263–1271.
   PubMed Web of Science ®Google Scholar
• Alexianu, M. E., Robbins, E., Carswell, S., & Appel, S. H. (1998). 1 alpha,25 dihydroxyvitamin D-3-dependent up-regulation of calcium-binding proteins in motoneuron cells. Journal of Neuroscience Research, 51(1), 58–66.
   Web of Science ®Google Scholar
• Anderson, P., May, B., & Morris, H. (2003). Vitamin D metabolism: New concepts and clinical implications. Clinical Biochemist Reviews, 24(1), 13–26.
   Google Scholar
• Baimbridge, K. G., Celio, M. R., & Rogers, J. H. (1992). Calcium-binding protein in the nervous-system. Trends in Neurosciences, 15(8), 303–308.
   Google Scholar
• Baksi, S. N., & Hughes, M. J. (1982). Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex. Brain Research, 242(2), 387–390.
   Google Scholar
• Becker, A., Eyles, D. W., McGrath, J. J., & Grecksch, G. (2005). Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behavioural Brain Research, 161(2), 306–312.
   PubMed Web of Science ®Google Scholar
• Behl, C. (1999). Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches. Progress in Neurobiology, 57(3), 301–323.
   Google Scholar
• Bourin, M. R. N., & Dailly, E. (2003). Nicotinic receptors and Alzheimer's disease. Current Medical Research and Opinion, 19, 169–177.
   PubMed Web of Science ®Google Scholar
• Bourre, J. M. (2006). Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 2: Macronutrients. Journal of Nutrition, Health & Aging, 10(5), 386–399.
   PubMedGoogle Scholar
• Brewer, L. D., Porter, N. M., Kerr, D. S., Landfield, P. W., & Thibault, O. (2006). Chronic 1 alpha,25-(OH)(2) vitamin D-3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium, 40(3), 277–286.
   PubMed Web of Science ®Google Scholar
• Brewer, L. D., Thibault, V., Chen, K. C., Langub, M. C., Landfield, P. W., & Porter, N. M. (2001). Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. Journal of Neuroscience, 21(1), 98–108.
   PubMed Web of Science ®Google Scholar
• Buell, J. S., & Dawson-Hughes, B. (2008). Vitamin D and neurocognitive dysfunction: Preventing “D”ecline? Molecular Aspects of Medicine, 29(6), 415–422.
   PubMed Web of Science ®Google Scholar
• Burne, T. H. J., McGrath, J. J., Eyles, D. W., & Mackay-Sim, A. (2005). Behavioural characterization of vitamin D receptor knockout mice. Behavioural Brain Research, 157(2), 299–308.
   PubMed Web of Science ®Google Scholar
• Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends in Molecular Medicine, 7(12), 548–554.
   PubMed Web of Science ®Google Scholar
• Celio, M. R. (1990). Calbindin-D-28K parvalbumin in the rat nervous-system. Neuroscience, 35(2), 375–475.
   Google Scholar
• Choi, D. W. (1992). Excitotoxic cell-death. Journal of Neurobiology, 23(9), 1261–1276.
   PubMedGoogle Scholar
• Deviragh, P. A., Haglid, K. G., & Celio, M. R. (1989). Parvalbumin increases in the caudate putamen of rats with vitamin-D hypervitaminosis. Proceedings of the National Academy of Sciences of the United States of America, 86(10), 3887–3890.
   Google Scholar
• Diamond, B., Johnson, S., Torsney, K., Morodan, J., Prokop, B., Davidek, D., (2003). Complementary and alternative medicines in the treatment of dementia: An evidence-based review. Drugs and Aging, 20(13), 981–998.
   Google Scholar
• Disterhoft, J. F., Moyer, J. R., & Thompson, L. T. (1994). The calcium rationale in aging and Alzheimer's disease. Evidence from an animal model of normal aging. Annals of the New York Academy of Sciences, 747, 382–406.
   Google Scholar
• Ebert, R., Schutze, N., Adamski, J., & Jakob, F. (2006). Vitamin D signaling is modulated on multiple levels in health and disease. Molecular and Cellular Endocrinology, 248(1–2), 149–159.
   Google Scholar
• Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., (2002). M. Dietary intake of antioxidants and risk of Alzheimer disease. Journal of the American Medical Association, 287(24), 3223–3229.
   PubMed Web of Science ®Google Scholar
• Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., & Feron, F. (2003). Vitamin D-3 and brain development. Neuroscience, 118(3), 641–653.
   PubMed Web of Science ®Google Scholar
• Eyles, D. W., Rogers, F., Buller, K., McGrath, J. J., Ko, P., French, K., (2006). Developmental vitamin D (DVD) deficiency in the rat alters adult behaviour independently of HPA function. Psychoneuroendocrinology, 31(8), 958–964.
   Google Scholar
• Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. Journal of Chemical Neuroanatomy, 29(1), 21–30
   PubMed Web of Science ®Google Scholar
• Finkbeiner, S., & Greenberg, M. E. (1998). Ca2+ channel-regulated neuronal gene expression. Journal of Neurobiology, 37(1), 171–189.
   Google Scholar
• Garcia, P., Youssef, I., Utvik, J. K., Florent-Bechard, S., Barthelemy, V., Malaplate-Armand, C., (2010). Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease. Journal of Neuroscience, 30(22), 7516–7527.
   PubMed Web of Science ®Google Scholar
• Garcion, E., Nataf, S., Berod, A., Darcy, F., & Brachet, P. (1997). 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Research. Molecular Brain Research, 45(2), 255–267.
   PubMedGoogle Scholar
• Garcion, E., Sindji, L., Leblondel, G., Brachet, P., & Darcy, F. (1999). 1,25-dihydroxyvitamin D-3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. Journal of Neurochemistry, 73(2), 859–866.
   PubMed Web of Science ®Google Scholar
• Garcion, E., Sindji, L., Montero-Menei, C., Andre, C., Brachet, P., & Darcy, F. (1998). Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D-3. Glia, 22(3), 282–294.
   PubMed Web of Science ®Google Scholar
• Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002). New clues about vitamin D functions in thenervous system. Trends in Endocrinology and Metabolism, 13(3), 100–105.
   PubMed Web of Science ®Google Scholar
• Gibson, G. E., & Peterson, C. (1987). Calcium and the aging nervous-system. Neurobiology of Aging, 8(4), 329–343.
   PubMed Web of Science ®Google Scholar
• Gillette Guyonnet, S., Abellan Van Kan, G., Andrieu, S., Barberger Gateau, P., Berr, C., Bonnefoy, M., (2007). IANA task force on nutrition and cognitive decline with aging. Journal of Nutrition, Health & Aging, 11(2), 132–152.
   Google Scholar
• Greenwood, C. E., & Winocur, G. (2005). High-fat diets, insulin resistance and declining cognitive function. Neurobiology of Aging, 26(Suppl. 1), 42–45.
   PubMed Web of Science ®Google Scholar
• Haan, M. N., & Wallace, R. (2004). Can dementia be prevented? Brain aging in a population-based context. Annual Review of Public Health, 25, 1–24.
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
   PubMed Web of Science ®Google Scholar
• Hoozemans, J. J. M., Veerhuis, R., Rozemuller, J. M., & Eikelenboom, P. (2006). Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. International Journal of Developmental Neuroscience, 24(2–3), 157–165.
   Google Scholar
• Iacopino, A. M., & Christakos, S. (1990). Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene -expression in aging and neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America, 87(11), 4078–4082.
   Google Scholar
• Ibi, M., Sawada, H., Nakanishi, M., Kume, T., Katsuki, H., Kaneko, S., (2001). Protective effects of 1 alpha,25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology, 40(6), 761–771.
   PubMed Web of Science ®Google Scholar
• Kakuda, N., Funamoto, S., Yagishita, S., Takami, M., Osawa, S., Dohmae, N., (2006). Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by beta-secretase. Journal of Biological Chemistry, 281(21), 14776–14786.
   Google Scholar
• Kalueff, A. V., Lou, Y. R., Laaksi, L., & Tuohimaa, P. (2004). Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport, 15(8), 1271–1274.
   PubMed Web of Science ®Google Scholar
• Kang, H. J., & Schuman, E. M. (2000). Intracellular Ca2+ signaling is required for neurotrophin-induced potentiation in the adult rat hippocampus. Neuroscience Letters, 282(3), 141–144.
   Google Scholar
• Kapur, A., Yeckel, M. F., Gray, R., & Johnston, D. (1998). L-type calcium channels are required for one form of hippocampal mossy fiber LTP. Journal of Neurophysiology, 79(4), 2181–2190.
   PubMed Web of Science ®Google Scholar
• Khachaturian, Z. S. (1989). The role of calcium regulation in brain aging: Reexamination of a hypothesis. Aging (Milan), 1(1), 17–34.
   Google Scholar
• Landfield, P. W., & Cadwallader-Neal, L. (1998). Long-term treatment with calcitriol (1,25(OH)(2) vit D-3) retards a biomarker of hippocampal aging in rats. Neurobiology of Aging, 19(5), 469–477.
   Google Scholar
• Landfield, P. W., Thibault, O., Mazzanti, M. L., Porter, N. M., & Kerr, D. S. (1992). Mechanisms of neuronal death in brain aging and Alzheimer's-disease—Role of endocrine-mediated calcium dyshomeostasis. Neurobiology of Aging, 23(9), 1247–1260.
   Google Scholar
• Lipton, S. A. (2006). Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nature Reviews. Drug Discovery, 5(2), 160–170.
   PubMed Web of Science ®Google Scholar
• Massa, S. M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J. N., (2010). Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. Journal of Clinical Investigation, 120(5), 1774–1785.
   PubMed Web of Science ®Google Scholar
• McCann, J. C., & Ames, B. N. (2008). Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB Journal, 22(4), 982–1001.
   PubMed Web of Science ®Google Scholar
• McGrath, J., Eyles, D., Mowry, B., Yolken, R., & Buka, S. (2003). Low maternal vitamin D as a risk factor for schizophrenia: A pilot study using banked sera. Schizophrenia Research, 63(1–2), 73–78.
   Google Scholar
• McGrath, J., Scragg, R., Chant, D., Eyles, D., Burne, T., & Obradovic, D. (2007). No association between serum 25-Hydroxyvitamin D-3 level and performance on psychometric tests in NHANES III. Neuroepidemiology, 29, 49–54.
   PubMed Web of Science ®Google Scholar
• McGrath, J. J., Feron, F. P., Burne, T. H. J., Mackay-Sim, A., & Eyles, D. W. (2004). Vitamin D-3—Implications for brain development. Journal of Steroid Biochemistry and Molecular Biology, 89–0(1–5), 557–560.
   Google Scholar
• Meszaros, J. G., Karin, N. J., Akanbi, K., & FarachCarson, M. C. (1996). Down-regulation of L-type Ca2+ channel transcript levels by 1,25-dihydroxyvitamin D-3—Osteoblastic cells express L-type alpha(1C) Ca2+ channel isoforms. Journal of Biological Chemistry, 271(51), 32981–32985.
   Google Scholar
• Mitrovic, B., Stpierre, B. A., Mackenziegraham, A. J., & Merrill, J. E. (1994). The role of nitric-oxide in glial pathology. Annals of the New York Academy of Sciences, 738, 436–446.
   PubMed Web of Science ®Google Scholar
• Moyer, J. R., Thompson, L. T., Black, J. P., & Disterhoft, J. F. (1992). Nimodipine increases excitability of rabbit CA1 pyramidial neurons in an age-dependent and concentration-dependent manner. Journal of Neurophysiology, 68(6), 2100–2109.
   Google Scholar
• Neveu, I., Naveilhan, P., Baudet, C., Brachet, P., & Metsis, M. (1994). 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport, 6(1), 124–126.
   PubMed Web of Science ®Google Scholar
• Norman, A. W. (2006). Minireview: Vitamin D receptor; New assignments for an already busy receptor. Endocrinology, 147(12), 5542–5548.
   PubMed Web of Science ®Google Scholar
• Norris, C. M., Halpain, S., & Foster, T. C. (1998). Reversal of age-related alterations in synaptic plasticity by blockade of L-type Ca2+ channels. Journal of Neuroscience, 18(9), 3171–3179.
   Google Scholar
• Paxinos, G., & Watson, C. (2004). The Rat Brain in Stereotaxic Coordinates. 5th ed. San Diego, CA: Academic press.
   Google Scholar
• Poucet, B. (1993). Spatial cognitive maps in animals—New hypotheses on their structure and neural mechanisms. Psychology Review, 100(2), 163–182.
   Google Scholar
• Przybelski, R. J., & Binkley, N. C. (2007). Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Archives of Biochemistry and Biophysics, 460(2), 202–205.
   PubMedGoogle Scholar
• Reeves, P. G. (1997). Components of the AIN-93 diets as improvements in the AIN-76A diet. Journal of Nutrition, 127, S838–S841.
   PubMed Web of Science ®Google Scholar
• Segaert, S., & Bouillon, R. (1998). Vitamin D and regulation of gene expression. Current opinion in Clinical Nutrition and Metabolic Care, 1(4), 347–354.
   Google Scholar
• Siegel, G. J., & Chauhan, N. B. (2000). Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Research. Brain Research Reviews, 33(2–3), 199–227.
   PubMedGoogle Scholar
• Sipos, E., Kurunczi, A., Kasza, A., Horvath, J., Felszeghy, K., Laroche, S., (2007). Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer's disease. Neuroscience, 147(1), 28–36.
   Google Scholar
• Sonnenberg, J., Luine, V. N., Krey, L. C., & Christakos, S. (1986). 1,25-dihydroxyvitamin-D3 treatment results in increased choline-acetyltransferase activity in specific brain nuclei. Endocrinology, 118(4), 1433–1439.
   PubMed Web of Science ®Google Scholar
• Teyler, T. J., Cavus, I., & Coussens, C. (1995). Synaptic plasticity in the hippocampal slice—Functional consequences. Journal of Neuroscience Methods, 59(1), 11–17.
   Google Scholar
• Thibault, O., Hadley, R., & Landfield, P. W. (2001). Elevated postsynaptic [Ca2+](i) and L-type calcium channel activity in aged hippocampal neurons: Relationship to impaired synaptic plasticity. Journal of Neuroscience, 21(24), 9744–9756.
   Google Scholar
• Thibault, O., & Landfield, P. W. (1996). Increase in single L-type calcium channels in hippocampal neurons during aging. Science, 272(5264), 1017–1020.
   PubMed Web of Science ®Google Scholar
• Thibault, O., Porter, N. M., Chen, K. C., Blalock, E. M., Kaminker, P. G., Clodfelter, G. V., (1998). Calcium dysregulation in neuronal aging and Alzheimer's disease: History and new directions. Cell Calcium, 24(5–6), 417–433.
   Google Scholar
• Tran, M. H., Yamada, K., & Nabeshima, T. (2002). Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: A minireview. Peptides, 23(7), 1271–1283.
   PubMedGoogle Scholar
• Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., (2003). Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: A case–control study. British Journal of Nutrition, 89(4), 483–489.
   PubMed Web of Science ®Google Scholar
• Veng, L. M., Mesches, M. H., & Browning, M. D. (2003). Age-related working memory impairment is correlated with increases in the L-type calcium channel protein alpha1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment. Brain Research. Molecular Brain Research, 110(2), 193–202.
   Google Scholar
• Wang, J. Y., Wu, J. N., Cherng, T. L., Hoffer, B. J., Chen, H. H., Borlongan, C. V., (2001). Vitamin D-3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Research, 904(1), 67–75.
   PubMed Web of Science ®Google Scholar
• Weih, M., Wiltfang, J., & Kornhuber, J. (2007). Non-pharmacologic prevention of Alzheimer's disease: Nutritional and life-style risk factors. Journal of Neural Transmission, 114(9), 1187–1197.
   Google Scholar
• Wion, D., Macgrogan, D., Neveu, I., Jehan, F., Houlgatte, R., & Brachet, P. (1991). 1,25-dihydroxyvitamin-D3 is a potent inducer of nerve growth-factor synthesis. Journal of Neuroscience Research, 28(1), 110–114.
   PubMed Web of Science ®Google Scholar
• Woo, N. H., & Lu, B. (2006). Regulation of cortical interneurons by neurotrophins: From development to cognitive disorders. Neuroscientist, 12(1), 43–56.
   Google Scholar
• Yamin, G. (2009). NMDA receptor–dependent signaling pathways that underlie amyloid b-protein disruption of LTP in the hippocampus. Journal of Neuroscience Research, 87, 1729–1736.
   PubMed Web of Science ®Google Scholar